Overall, the largest benefi t of aspirin (in any dose) appeared
during the fi rst year after randomization (RR = 0.62). However,
only one study (APACC) scheduled a protocol examination at
1 year; there were also substantial numbers of patients in CALGB
9270 who had early examinations.